Skip to main content
. 2012 Aug 31;80(4):1045–1060. doi: 10.3797/scipharm.1206-09

Tab. 4.

Stability study data of different BPO gellified emulsions

Formulation Day Color Homogeneity pH % Drug content

4°C 25°C 4°C 25°C 4°C 25°C 4°C 25°C
F1 0 White White +++ +++ 6.31 6.31 104 104
30 White White +++ +++ 6.26 6.26 104 103
60 White White +++ +++ 6.22 6.21 102 101
90 White White +++ +++ 6.2 6.18 98 99

F2 0 White White +++ +++ 6.56 6.56 100 100
30 White White +++ +++ 6.5 6.5 100 99
60 White White +++ +++ 6.4 6.38 98 99
90 White White +++ +++ 6.36 6.37 96 97

F3 0 White White +++ +++ 6.25 6.25 102 102
30 White White +++ +++ 6.23 6.18 102 101
60 White White +++ +++ 6.19 6.2 99 97
90 White White +++ +++ 6.18 6.18 96 96

F4 0 White White +++ +++ 6.19 6.19 103 103
30 White White +++ +++ 6.14 6.16 102 103
60 White White +++ +++ 6.12 6.12 98 101
90 White White +++ +++ 6.09 6.12 96 98